Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for amlodipine benzenesulfonate tablets
Announcement of Yiping Hong (300723.SZ): The company's wholly-owned subsidiary, Guangzhou Yiping Hong Pharmaceutical Co., Ltd., recently received a notification from the country...
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Group Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the amlodipine besylate tablet. Indications for amlodipine besylate tablets include: hypertension and coronary artery disease (CAD).
Related Articles

GAD Environmental Technology (300854.SZ) shareholder Liu Qingsong received a warning letter from the Shenzhen Securities Regulatory Bureau.

COMBA (02342) exercised its option to purchase shares, resulting in the issuance of 13.68 million shares.

CMST Development (600787.SH) plans to increase the capital of Zhongchuanghengke Internet of Things System Co., Ltd. through debt-to-equity conversion.
GAD Environmental Technology (300854.SZ) shareholder Liu Qingsong received a warning letter from the Shenzhen Securities Regulatory Bureau.

COMBA (02342) exercised its option to purchase shares, resulting in the issuance of 13.68 million shares.

CMST Development (600787.SH) plans to increase the capital of Zhongchuanghengke Internet of Things System Co., Ltd. through debt-to-equity conversion.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025